Renal allograft recipients fail to increase interferon-γ during invasive fungal diseases

Area of Science:

• Immunology
• Transplantation Medicine
• Infectious Diseases

Background:

• Invasive fungal diseases (IFDs) are a significant cause of mortality in renal allograft recipients.
• Previous research indicated the clinical utility of adjunctive recombinant human interferon-γ (IFN-γ) therapy for IFDs post-renal transplantation.
• Understanding the immune response in these patients is crucial for optimizing treatment strategies.

Purpose of the Study:

• To develop and validate a rapid peripheral blood-based quantitative real-time PCR assay for cytokine imbalance profiling.
• To investigate the cytokine profiles of renal transplant patients with IFDs compared to stable recipients.
• To elucidate the immunological basis for the therapeutic efficacy of IFN-γ in IFD patients.

Main Methods:

• Development of a quantitative real-time PCR assay for cytokine profiling using peripheral blood.
• Analysis of cytokine levels, including interferon-γ, IL-10, and TNF-α, in renal transplant patients with IFDs.
• Comparison of cytokine profiles between patients with IFDs and stable renal transplant recipients.

Main Results:

• Renal transplant patients with IFDs demonstrated an inadequate interferon-γ response to fungal infections.
• These patients exhibited reduced levels of Interleukin-10 (IL-10) and elevated levels of Tumor Necrosis Factor-α (TNF-α) compared to stable recipients.
• The developed PCR assay enabled accurate profiling of these critical cytokine imbalances.

Conclusions:

• Preliminary findings suggest a specific cytokine dysregulation in renal allograft recipients suffering from invasive fungal diseases.
• The observed immune profile, characterized by impaired IFN-γ response and altered IL-10/TNF-α balance, provides a rationale for using adjunctive human IFN-γ therapy.
• This study highlights the potential of cytokine profiling for guiding therapeutic interventions in post-transplant infections.